Economic evaluation of prenatal population screening for fragile X syndrome

Community Genetics

Volumn 8, Issue 2, 2005, Pages 68-72

  Hollingsworth, Bruce ^a   Harris, Anthony ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cost benefit analysis; Fragile X syndrome; Genetic testing; Population screening

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; FEMALE; FRAGILE X SYNDROME; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MASS SCREENING; MEDICAL INFORMATION; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SOCIAL ASPECT;

AUSTRALIA; COST-BENEFIT ANALYSIS; FEMALE; FRAGILE X SYNDROME; GENETIC SCREENING; HUMANS; MODELS, ECONOMIC; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 20444459477     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084773     Document Type: Article

References (10)

1. Kaufmann WE, Reiss AL: Molecular and cellular genetics of fragile X syndrome. Am J Med Genet 1999;88:11-24.
2. Commonwealth of Australia, Medical Services Advisory Committee: MSAC Genetic Test for Fragile X Syndrome Report No 1035, 2002.
3. Turner G, Robinson H, Laing S, Purvis-Smith S: Preventative screening for the fragile X syndrome. NEJM 1986;315:607-609.
4. Vintzileos A, Ananth C, Fisher A, Smulian J, Day-Salvatore D, Beazoglou T, Knuppel R: Economic evaluation of prenatal carrier screening for fragile X syndrome. J Matern Fetal Med 1999;8:168-172.
5. Commonwealth of Australia, Medical Services Advisory Committee: MSAC Nuchal Translucency Measurement in the First Trimester of Pregnancy for Screening of Down Syndrome and Autosomal Trisomies Report, 2002.
6. Cairns J: Discounting in economic evaluation; in Drummond M, McGuire A (eds): Economic Evaluation in Health Care. Merging Theory with Practice. New York, Oxford University Press, 2001.
7. Wald N, Kennard A, Hackshaw A: Antenatal screening for Down's syndrome. J Med Screen 1997;4:181-246.
8. Wildhagen M, van Os T, Polder J, Ten Kate L, Habbema J: Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general population. Community Genet 1998;1:36-47.
9. SABDR (South Australia Births Defect Register) Annual Report. Adelaide, 1998.
10. Harris R, Washington A, Nease R, Kuppermann M: Cost utility of prenatal diagnosis and the risk-based threshold. Lancet 2004;363:276-282.